Seeing Is Believing
RANI is currently covered by 6 analysts with an average price target of $9.52. This is a potential upside of $8.1 (570.42%) from yesterday's end of day stock price of $1.42.
Rani Therapeutics Holdings's activity chart (see below) currently has 5 price targets and 22 ratings on display. The stock rating distribution of RANI is 100% BUY.
Analysts average stock forecasts to be materialized ratio is 33.33% with an average time for these price targets to be met of 46 days.
Highest price target for RANI is $17, Lowest price target is $9, average price target is $9.52.
Most recent stock forecast was given by MITCHELL KAPOOR from HC WAINWRIGHT on 19-Nov-2024. First documented stock forecast 24-Aug-2021.
Currently out of the existing stock ratings of RANI, 17 are a BUY (100%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
$9
$7.6 (542.86%)
$9
1 months 4 days ago
(19-Nov-2024)
0/10 (0%)
$6.98 (345.54%)
Buy
$17
$15.6 (1114.29%)
$8
4 months 21 days ago
(02-Aug-2024)
0/4 (0%)
$14.33 (536.70%)
Buy
$9
$7.6 (542.86%)
8 months 26 days ago
(27-Mar-2024)
0/1 (0%)
$5.97 (197.03%)
Buy
$4
$2.6 (185.71%)
$15
1 years 1 months 8 days ago
(15-Nov-2023)
1/2 (50%)
$2.01 (101.01%)
146
Buy
$24
1 years 1 months 21 days ago
(02-Nov-2023)
1/1 (100%)
$6.24 (35.14%)
65
What is RANI (Rani Therapeutics Holdings) average time for price targets to be met?
Which analyst has the current highest performing score on RANI (Rani Therapeutics Holdings) with a proven track record?
Which analyst has the current lower performing score on RANI (Rani Therapeutics Holdings) with a proven track record?
Which analyst has the most public recommendations on RANI (Rani Therapeutics Holdings)?
Which analyst is the currently most bullish on RANI (Rani Therapeutics Holdings)?
Which analyst is the currently most reserved on RANI (Rani Therapeutics Holdings)?